Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A Koeth, Zeneng Wang, Bruce S Levison, Jennifer A Buffa, Elin Org, Brendan T Sheehy, Earl B Britt, Xiaoming Fu, Yuping Wu, Lin Li, Jonathan D Smith, Joseph A DiDonato, Jun Chen, Hongzhe Li, Gary D Wu, James D Lewis, Manya Warrier, J Mark Brown, Ronald M Krauss, W H Wilson Tang, Frederic D Bushman, Aldons J Lusis, Stanley L Hazen, Robert A Koeth, Zeneng Wang, Bruce S Levison, Jennifer A Buffa, Elin Org, Brendan T Sheehy, Earl B Britt, Xiaoming Fu, Yuping Wu, Lin Li, Jonathan D Smith, Joseph A DiDonato, Jun Chen, Hongzhe Li, Gary D Wu, James D Lewis, Manya Warrier, J Mark Brown, Ronald M Krauss, W H Wilson Tang, Frederic D Bushman, Aldons J Lusis, Stanley L Hazen
Abstract
Intestinal microbiota metabolism of choline and phosphatidylcholine produces trimethylamine (TMA), which is further metabolized to a proatherogenic species, trimethylamine-N-oxide (TMAO). We demonstrate here that metabolism by intestinal microbiota of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis in mice. Omnivorous human subjects produced more TMAO than did vegans or vegetarians following ingestion of L-carnitine through a microbiota-dependent mechanism. The presence of specific bacterial taxa in human feces was associated with both plasma TMAO concentration and dietary status. Plasma L-carnitine levels in subjects undergoing cardiac evaluation (n = 2,595) predicted increased risks for both prevalent cardiovascular disease (CVD) and incident major adverse cardiac events (myocardial infarction, stroke or death), but only among subjects with concurrently high TMAO levels. Chronic dietary L-carnitine supplementation in mice altered cecal microbial composition, markedly enhanced synthesis of TMA and TMAO, and increased atherosclerosis, but this did not occur if intestinal microbiota was concurrently suppressed. In mice with an intact intestinal microbiota, dietary supplementation with TMAO or either carnitine or choline reduced in vivo reverse cholesterol transport. Intestinal microbiota may thus contribute to the well-established link between high levels of red meat consumption and CVD risk.
Figures
References
- Bernstein AM, et al. Major dietary protein sources and risk of coronary heart disease in women. Circulation. 2010;122:876–883.
- Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271–2283.
- Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutrit. 2010;91:535–546.
- Bibbins-Domingo K, et al. Projected effect of dietary salt reductions on future cardiovascular disease. The N. Engl. J. Med. 2010;362:590–599.
- Hansen ES. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis--a review of the epidemiological evidence. Mutat. Res. 1990;239:163–179.
- Turnbaugh PJ, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–484.
- Turnbaugh PJ, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031.
- Goodman AL, Gordon JI. Our unindicted coconspirators: human metabolism from a microbial perspective. Cell Metab. 2010;12:111–116.
- Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63.
- Bremer J. Carnitine--metabolism and functions. Physiol. Rev. Suppl. 1983;63:1420–1480.
- Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu. Rev. Nutr. 1998;18:39–61.
- Stanley CA. Carnitine deficiency disorders in children. Ann. N. Y. Acad. Sci. 2004;1033:42–51.
- Demarquoy J, et al. Radioisotopic determination of L-carnitine content in foods commonly eaten in western countries. Food Chem. 2004;86:137–142.
- Rigault C, Mazue F, Bernard A, Demarquoy J, Le Borgne F. Changes in l-carnitine content of fish and meat during domestic cooking. Meat Sci. 2008;78:331–335.
- Ley RE, et al. Evolution of mammals and their gut microbes. Science (New York, N.Y.) 2008;320:1647–1651.
- Muegge BD, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science. 2011;332:970–974.
- Zimmer J, et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur. J. Clin. Nutr. 2012;66:53–60.
- Wu GD, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science (New York, N.Y.) 2011;334:105–108.
- Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–241.
- Ley RE, et al. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U S A. 2005;102:11070–11075.
- Febbraio M, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000;105:1049–1056.
- Suzuki H, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997;386:292–296.
- Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331–340.
- Spann NJ, et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell. 2012;151:138–152.
- Rader DJ. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 2003;92:42J–49J.
- Jia L, Betters JL, Yu L. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu. Rev. Physiol. 2011;73:239–259.
- Schwarz M, Russell DW, Dietschy JM, Turley SD. Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 1998;39:1833–1843.
- Repa JJ, et al. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol .Chem. 2000;275:39685–39692.
- Gulewitsch W, Krimberg R. Zur Kenntnis der Extrakivstoffe der Muskein, II. Mitteilung. Uber das Carnitin. Hoppe-Seyler’s Z. Physiol. Chem. 1905:326–330.
- Rebouche CJ, Chenard CA. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J. Nutr. 1991;121:539–546.
- Rebouche CJ, Mack DL, Edmonson PF. L-Carnitine dissimilation in the gastrointestinal tract of the rat. Biochemistry. 1984;23:6422–6426.
- Zhang AQ, Mitchell SC, Smith RL. Dietary precursors of trimethylamine in man: a pilot study. Food Chem. Toxicol. 1999;37:515–520.
- Delany JP, snook JT, Vivian VM, Cashmere K. Metabolic effects of a carnitine-free diet fed to college students. Fed. Proc. 1986;45:815.
- Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J. Nutr. 2003;133:1302–1307.
- Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am. J. Clin. Nutr. 2009;89:1607S–1612S.
- Key TJ, et al. Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am. J. Clin. Nutr. 1999;70:516S–524S.
- Estruch R, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N. Engl. J. Med. 2013
- Brown MS, Goldstein JL. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science. 1974;185:61–63.
- Charach G, Rabinovich A, Argov O, Weintraub M, Rabinovich P. The role of bile Acid excretion in atherosclerotic coronary artery disease. Int. J. Vasc. Med. 2012;2012949672
- Charach G, et al. Decreased fecal bile acid output in patients with coronary atherosclerosis. J. Med. 1998;29:125–136.
- Lu Y, Feskens EJ, Boer JM, Muller M. The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis. 2010;210:14–27.
- Miyake JH, et al. Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler. Thromb. Vasc. Biol. 2002;22:121–126.
- Post SM, de Crom R, van Haperen R, van Tol A, Princen HM. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein. Arterioscler. Thromb. Vasc. Biol. 2003;23:892–897.
- Zong C, et al. Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice. Exp. Biol. Med. (Maywood) 2012;237:194–200.
- Altmann SW, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201–1204.
- Bai C, Biwersi J, Verkman AS, Matthay MA. A mouse model to test the in vivo efficacy of chemical chaperones. J. Pharmacol. Toxicol. Methods. 1998;40:39–45.
- Mello CC, Barrick D. Measuring the stability of partly folded proteins using TMAO. Protein Sci. 2003;12:1522–1529.
- Liberles SD, Buck LB. A second class of chemosensory receptors in the olfactory epithelium. Nature. 2006;442:645–650.
- Suska A, Ibanez AB, Lundstrom I, Berghard A. G protein-coupled receptor mediated trimethylamine sensing. Biosensors & bioelectronics. 2009;25:715.
- Cordain L, et al. Origins and evolution of the Western diet: health implications for the 21st century. The Am. J. Clin. Nutrit. 2005;81:341–354.
- Liszt K, et al. Characterization of bacteria, clostridia and Bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting. Ann. Nutr. Metab. 2009;54:253–257.
- Elssner T, Preusser A, Wagner U, Kleber HP. Metabolism of L(−)-carnitine by Enterobacteriaceae under aerobic conditions. FEMS Microbiol. Lett. 1999;174:295–301.
- Moller B, Hippe H, Gottschalk G. Degradation of various amine compounds by mesophilic clostridia. Arch. Microbiol. 1986;145:85–90.
- Eckburg PB, et al. Diversity of the human intestinal microbial flora. Science (New York, N.Y.) 2005;308:1635–1638.
- Kleber HP. Bacterial carnitine metabolism. FEMS Microbiol Lett. 1997;147:1–9.
- Hedayati SS. Dialysis-related carnitine disorder. Semin. Dial. 2006;19:323–328.
- Mingorance C, Rodriguez-Rodriguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. Vasc. Health Risk Manag. 2011;7:169–176.
- The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol. 1989;129:687–702.
- Chen J. Powerful statistical analysis for associating microbiomes to enviromental covariates using generalized Unifrac distances. Bioinformatics. 2012;28:2106–2113.
- Willems G. A robust hotelling test. Metrika. 2002;55:125–138.
Source: PubMed